Caxton Associates (New York)’s Relay Therapeutics RLAY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-107,568	Closed	-$701K	–	631
2024 Q2	$701K	Sell	107,568 -23,248	-18%	-$152K	0.02%	289
2024 Q1	$1.09M	Sell	130,816 -148,285	-53%	-$1.23M	0.06%	206
2023 Q4	$3.07M	Buy	279,101 +241,247	+637%	+$2.66M	0.16%	79
2023 Q3	$318K	Buy	+37,854	New	+$318K	0.04%	299